A Virtual Ward Model of Care for Patients With COVID-19: Retrospective Single-Center Clinical Study
- PMID: 33529157
- PMCID: PMC7879714
- DOI: 10.2196/25518
A Virtual Ward Model of Care for Patients With COVID-19: Retrospective Single-Center Clinical Study
Abstract
Background: COVID-19 has necessitated the implementation of innovative health care models in preparation for an influx of patients. A virtual ward model delivers clinical care remotely to patients in isolation. We report on an Australian cohort of patients with COVID-19 treated in a virtual ward.
Objective: The aim of this study was to describe and evaluate the safety and efficacy of a virtual ward model of care for an Australian cohort of patients with COVID-19.
Methods: Retrospective clinical assessment was performed for 223 patients with confirmed COVID-19 treated in a virtual ward in Brisbane, Australia, from March 25 to May 15, 2020. Statistical analysis was performed for variables associated with the length of stay and hospitalization.
Results: Of 223 patients, 205 (92%) recovered without the need for escalation to hospital care. The median length of stay in the virtual ward was 8 days (range 1-44 days). In total, 18 (8%) patients were referred to hospital, of which 6 (33.3%) were discharged after assessment at the emergency department. Furthermore, 12 (5.4%) patients were admitted to hospital, of which 4 (33.3%) required supplemental oxygen and 2 (16.7%) required mechanical ventilation. No deaths were recorded. Factors associated with escalation to hospital care were the following: hypertension (odds ratio [OR] 3.6, 95% CI 1.28-9.87; P=.01), sputum production (OR 5.2, 95% CI 1.74-15.49; P=.001), and arthralgia (OR 3.8, 95% CI 1.21-11.71; P=.02) at illness onset and a polymerase chain reaction cycle threshold of ≤20 on a diagnostic nasopharyngeal swab (OR 5.0, 95% CI 1.25-19.63; P=.02).
Conclusions: Our results suggest that a virtual ward model of care to treat patients with COVID-19 is safe and efficacious, and only a small number of patients would potentially require escalation to hospital care. Further studies are required to validate this model of care.
Keywords: COVID-19; efficacy; hospital; innovation; model; remote care; safety; telemedicine; virtual health care; virtual ward.
©Olivia R Ferry, Emma C Moloney, Owen T Spratt, Gerald F M Whiting, Cameron J Bennett. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 10.02.2021.
Conflict of interest statement
Conflicts of Interest: None declared.
Figures
References
-
- Rolling updates on coronavirus disease (COVID-19) World Health Organization. 2020. Jul 31, [2020-06-04]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-a....
-
- Webster P. Virtual health care in the era of COVID-19. Lancet. 2020 Apr 11;395(10231):1180–1181. doi: 10.1016/S0140-6736(20)30818-7. http://europepmc.org/abstract/MED/32278374 - DOI - PMC - PubMed
-
- Flodgren G, Rachas A, Farmer A, Inzitari M, Shepperd S. Interactive telemedicine: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2015 Sep 07;(9):CD002098. doi: 10.1002/14651858.CD002098.pub2. http://europepmc.org/abstract/MED/26343551 - DOI - PMC - PubMed
-
- Khairat S, Meng C, Xu Y, Edson B, Gianforcaro R. Interpreting COVID-19 and Virtual Care Trends: Cohort Study. JMIR Public Health Surveill. 2020 Apr 15;6(2):e18811. doi: 10.2196/18811. https://publichealth.jmir.org/2020/2/e18811/ - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
